This finding indicates Osteonectin as an important biomarker for obesity-related risk stratification as it may be significantly expressed only in an obesogenic milieu or profoundly dyslipidemic one, while the TG/HDL ratio seems to be an accurate marker for organ impairment associated with metabolic dysregulation even before obesity is developed. This evidence concerns the gene SPARC and obesity disorder.